Lighthouse Pharmaceuticals
PrivateLast Round
Series A
Apr 23, 2026
Est. Valuation
$72M
Total Funding Raised
$61.2M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Lighthouse Pharmaceuticals is a biopharmaceutical company that develops small-molecule therapies for neurodegenerative and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lighthouse Pharmaceuticals Comparables
Compare Lighthouse Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Keystone Bio | 83% | |
| Sanofi | 65% | |
| INmune Bio Inc | 64% |
Lighthouse Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 23, 2026 | ||||
| Grant | Aug 22, 2025 |
Lighthouse Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Portfolia | Series A |
| National Institute on Aging | Grant |
| Marin Sonoma Impact Ventures | Series A |
| Double Point Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 11, 2026
Monthly visitors increased 823% MoM, reaching 406.
- Apr 23, 2026
$12M round led by Double Point Ventures
Recent news
Latest coverage and updates
- attends_eventJul 13, 2026
Lighthousepharma attended event AAIC 2026 on Jul 13th '26.
Lighthouse Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access